MedPath

A Randomized Controlled Study of Moxibustion in the Treatment of Shoulder-Hand Syndrome after Ischemic Stroke

Not Applicable
Not yet recruiting
Conditions
post-stroke shoulder-hand syndrome
Registration Number
ITMCTR2100005261
Lead Sponsor
The First Affiliated Hospital of He'nan University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Patients who meet the diagnostic criteria for stroke (including ischemic and hemorrhagic stroke) by computed tomography (CT) or magnetic resonance imaging (MRI);
2. Aged 18 to 75 years, the course of the disease does not exceed 12 months;
3. All vital signs after stroke are stable, meet the diagnostic criteria for shoulder-hand syndrome, and belong to stage I or II according to the staging criteria;
4. Those who have a clear consciousness and can perform and tolerate fine moxibustion treatment.

Exclusion Criteria

1. Patients with other serious diseases that may affect the results of treatment and threaten life, such as heart disease, liver disease, lung disease, kidney disease, diabetes, osteoporosis or bleeding tendency;
2. Patients who are pregnant, breastfeeding or planning to become pregnant;
3. Patients with severe cognitive impairment who cannot cooperate with treatment.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.